JACOB LEONARD S 4
4 · ANTARES PHARMA, INC. · Filed Aug 31, 2021
Insider Transaction Report
Form 4
JACOB LEONARD S
Director
Transactions
- Tax Payment
Common Stock
2021-08-27$4.00/sh−13,820$55,280→ 295,575 total - Award
Common Stock
2021-08-27$2.24/sh+24,679$55,281→ 309,395 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-27+24,679→ 0 totalExercise: $2.24From: 2021-08-27Exp: 2021-09-08→ Common Stock (24,679 underlying)
Footnotes (2)
- [F1]Represents the number of shares withheld by the company to cover the exercise price for the underlying stock option exercise. No shares were actually sold.
- [F2]The options vested and became exercisable one year from the grant date of September 9, 2011. The stock options were due to expire on September 8, 2021.